欧洲和美国初级保健提供者在诊断和治疗肠易激综合征方面的看法和做法:一项跨国调查。

IF 3.5 3区 医学 Q1 CLINICAL NEUROLOGY Neurogastroenterology and Motility Pub Date : 2024-11-20 DOI:10.1111/nmo.14967
Joel J Heidelbaugh, A Pali Hungin, Olafur S Palsson, Foteini Anastasiou, Lars Agreus, Pierluigi Fracasso, Heidi-Ingrid Maaroos, Jalena Rakik Matic, Juan M Mendive, Bohumil Seifert, Douglas A Drossman
{"title":"欧洲和美国初级保健提供者在诊断和治疗肠易激综合征方面的看法和做法:一项跨国调查。","authors":"Joel J Heidelbaugh, A Pali Hungin, Olafur S Palsson, Foteini Anastasiou, Lars Agreus, Pierluigi Fracasso, Heidi-Ingrid Maaroos, Jalena Rakik Matic, Juan M Mendive, Bohumil Seifert, Douglas A Drossman","doi":"10.1111/nmo.14967","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The knowledge and proficiency of primary care practitioners (PCPs) in diagnosing and managing irritable bowel syndrome (IBS) remain generally low and variable internationally. This variability is partly due to a lack of familiarity with the Rome Foundation diagnostic criteria and treatment guidelines for this condition.</p><p><strong>Methods: </strong>We conducted an electronic survey of PCPs in the United States and nine European countries to assess their understanding of IBS pathophysiology; the use of Rome IV criteria in diagnosis, knowledge of and frequency in prescribing various recommended treatments; and the likelihood of referring patients with suspected IBS to subspecialists.</p><p><strong>Results: </strong>Most PCPs in the United States and Europe perceive IBS as a diagnosis of exclusion rather than a definitive diagnosis. They also believe IBS is underdiagnosed in primary care and challenging to diagnose confidently. The majority of PCPs consider diet as a crucial component of IBS management. Notably, US PCPs reported greater confidence than their European counterparts in recommending dietary interventions such as increased dietary fiber, a low FODMAP diet, and gluten restriction. Conversely, both groups exhibited moderate to high confidence in recommending over-the-counter treatments. European PCPs showed greater confidence in treating IBS with antispasmodics and secretagogues, while US PCPs expressed greater confidence in prescribing neuromodulators. Additionally, US PCPs were more likely to refer patients with suspected IBS to a gastroenterologist, whereas both US and European PCPs showed similar referral patterns to dietitians and referred very few patients to mental health providers. Both US and European PCPs reported that IBS is moderately to extremely difficult to treat effectively and emphasized the importance of a strong and longitudinal doctor-patient relationship in managing the condition.</p><p><strong>Conclusion: </strong>Despite the Rome Foundation recommendations and criteria to support a positive diagnosis of IBS, most PCPs still rely on exclusionary investigations such as endoscopy and a serologic workup, while a significant percentage suggest referring patients to gastroenterologists.</p>","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":" ","pages":"e14967"},"PeriodicalIF":3.5000,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Perceptions and Practices of Primary Care Providers in Europe and the US in the Diagnosis and Treatment of Irritable Bowel Syndrome: A Multinational Survey.\",\"authors\":\"Joel J Heidelbaugh, A Pali Hungin, Olafur S Palsson, Foteini Anastasiou, Lars Agreus, Pierluigi Fracasso, Heidi-Ingrid Maaroos, Jalena Rakik Matic, Juan M Mendive, Bohumil Seifert, Douglas A Drossman\",\"doi\":\"10.1111/nmo.14967\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The knowledge and proficiency of primary care practitioners (PCPs) in diagnosing and managing irritable bowel syndrome (IBS) remain generally low and variable internationally. This variability is partly due to a lack of familiarity with the Rome Foundation diagnostic criteria and treatment guidelines for this condition.</p><p><strong>Methods: </strong>We conducted an electronic survey of PCPs in the United States and nine European countries to assess their understanding of IBS pathophysiology; the use of Rome IV criteria in diagnosis, knowledge of and frequency in prescribing various recommended treatments; and the likelihood of referring patients with suspected IBS to subspecialists.</p><p><strong>Results: </strong>Most PCPs in the United States and Europe perceive IBS as a diagnosis of exclusion rather than a definitive diagnosis. They also believe IBS is underdiagnosed in primary care and challenging to diagnose confidently. The majority of PCPs consider diet as a crucial component of IBS management. Notably, US PCPs reported greater confidence than their European counterparts in recommending dietary interventions such as increased dietary fiber, a low FODMAP diet, and gluten restriction. Conversely, both groups exhibited moderate to high confidence in recommending over-the-counter treatments. European PCPs showed greater confidence in treating IBS with antispasmodics and secretagogues, while US PCPs expressed greater confidence in prescribing neuromodulators. Additionally, US PCPs were more likely to refer patients with suspected IBS to a gastroenterologist, whereas both US and European PCPs showed similar referral patterns to dietitians and referred very few patients to mental health providers. Both US and European PCPs reported that IBS is moderately to extremely difficult to treat effectively and emphasized the importance of a strong and longitudinal doctor-patient relationship in managing the condition.</p><p><strong>Conclusion: </strong>Despite the Rome Foundation recommendations and criteria to support a positive diagnosis of IBS, most PCPs still rely on exclusionary investigations such as endoscopy and a serologic workup, while a significant percentage suggest referring patients to gastroenterologists.</p>\",\"PeriodicalId\":19123,\"journal\":{\"name\":\"Neurogastroenterology and Motility\",\"volume\":\" \",\"pages\":\"e14967\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2024-11-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurogastroenterology and Motility\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/nmo.14967\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurogastroenterology and Motility","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/nmo.14967","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:在国际范围内,初级保健医生(PCPs)诊断和处理肠易激综合征(IBS)的知识和熟练程度仍然普遍较低,而且参差不齐。造成这种差异的部分原因是对罗马基金会的诊断标准和治疗指南缺乏了解:我们对美国和九个欧洲国家的初级保健医生进行了一次电子调查,以评估他们对肠易激综合征病理生理学的了解程度;在诊断中使用罗马IV标准的情况;对各种推荐治疗方法的了解程度和处方频率;以及将疑似肠易激综合征患者转诊至亚专科医生的可能性:结果:美国和欧洲的大多数初级保健医生认为肠易激综合征是一种排除性诊断,而不是明确诊断。他们还认为肠易激综合征在初级保健中的诊断率很低,而且很难做出有把握的诊断。大多数初级保健医生认为饮食是肠易激综合征治疗的重要组成部分。值得注意的是,与欧洲的初级保健医生相比,美国的初级保健医生对推荐饮食干预措施(如增加膳食纤维、低 FODMAP 饮食和限制麸质)更有信心。相反,两组医生在推荐非处方治疗方面都表现出了中度到高度的信心。欧洲的初级保健医生对使用解痉剂和促泌剂治疗肠易激综合征表现出更大的信心,而美国的初级保健医生则对处方神经调节剂表现出更大的信心。此外,美国的初级保健医生更倾向于将疑似肠易激综合征患者转诊给消化科医生,而美国和欧洲的初级保健医生转诊给营养师的模式相似,转诊给心理健康服务提供者的患者很少。美国和欧洲的初级保健医生都表示,肠易激综合征很难得到有效治疗,并强调在治疗肠易激综合征的过程中建立稳固和长期的医患关系非常重要:结论:尽管罗马基金会提出了支持肠易激综合征阳性诊断的建议和标准,但大多数初级保健医生仍依赖于排除性检查,如内窥镜检查和血清学检查,而相当大比例的初级保健医生建议将患者转诊至消化科医生。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Perceptions and Practices of Primary Care Providers in Europe and the US in the Diagnosis and Treatment of Irritable Bowel Syndrome: A Multinational Survey.

Background: The knowledge and proficiency of primary care practitioners (PCPs) in diagnosing and managing irritable bowel syndrome (IBS) remain generally low and variable internationally. This variability is partly due to a lack of familiarity with the Rome Foundation diagnostic criteria and treatment guidelines for this condition.

Methods: We conducted an electronic survey of PCPs in the United States and nine European countries to assess their understanding of IBS pathophysiology; the use of Rome IV criteria in diagnosis, knowledge of and frequency in prescribing various recommended treatments; and the likelihood of referring patients with suspected IBS to subspecialists.

Results: Most PCPs in the United States and Europe perceive IBS as a diagnosis of exclusion rather than a definitive diagnosis. They also believe IBS is underdiagnosed in primary care and challenging to diagnose confidently. The majority of PCPs consider diet as a crucial component of IBS management. Notably, US PCPs reported greater confidence than their European counterparts in recommending dietary interventions such as increased dietary fiber, a low FODMAP diet, and gluten restriction. Conversely, both groups exhibited moderate to high confidence in recommending over-the-counter treatments. European PCPs showed greater confidence in treating IBS with antispasmodics and secretagogues, while US PCPs expressed greater confidence in prescribing neuromodulators. Additionally, US PCPs were more likely to refer patients with suspected IBS to a gastroenterologist, whereas both US and European PCPs showed similar referral patterns to dietitians and referred very few patients to mental health providers. Both US and European PCPs reported that IBS is moderately to extremely difficult to treat effectively and emphasized the importance of a strong and longitudinal doctor-patient relationship in managing the condition.

Conclusion: Despite the Rome Foundation recommendations and criteria to support a positive diagnosis of IBS, most PCPs still rely on exclusionary investigations such as endoscopy and a serologic workup, while a significant percentage suggest referring patients to gastroenterologists.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Neurogastroenterology and Motility
Neurogastroenterology and Motility 医学-临床神经学
CiteScore
7.80
自引率
8.60%
发文量
178
审稿时长
3-6 weeks
期刊介绍: Neurogastroenterology & Motility (NMO) is the official Journal of the European Society of Neurogastroenterology & Motility (ESNM) and the American Neurogastroenterology and Motility Society (ANMS). It is edited by James Galligan, Albert Bredenoord, and Stephen Vanner. The editorial and peer review process is independent of the societies affiliated to the journal and publisher: Neither the ANMS, the ESNM or the Publisher have editorial decision-making power. Whenever these are relevant to the content being considered or published, the editors, journal management committee and editorial board declare their interests and affiliations.
期刊最新文献
Unsupervised machine learning highlights the challenges of subtyping disorders of gut-brain interaction. A primer for the gastroenterology provider on psychosocial assessment of patients with disorders of gut-brain interaction. Correlation of deglutitive striated esophagus motor function and pharyngeal phase swallowing biomechanical events. Multidisciplinary behavioral therapy reduces rumination. The neurotensin receptor 1 agonist PD149163 alleviates visceral hypersensitivity and colonic hyperpermeability in rat irritable bowel syndrome model.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1